ArticleObesity facts2026

Real-World Comparison of Short-Term Adverse Events, Treatment Persistence, and Efficacy of Semaglutide and Tirzepatide: A Nationwide Multicenter Study.

Sema Hepşen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.